Doxorubicin

• ATC Code
• Indication
• NEMLC Recommendation
• Review Indicators
• Date Ratified

ATC CODE

• L01DB01

INDICATIONS AND NEMLC RECOMMENDATIONS

INDICATION AND NEMLC RECOMMENDATION 1

INDICATION

• Adjuvant breast cancer.

NEMLC RECOMMENDATION

• Approved
  (Doxorubicin plus cyclophosphamide (AC) ).

REVIEW INDICATORS

• None

DATE RATIFIED

• 27 November 2008

INDICATION AND NEMLC RECOMMENDATION 2

INDICATION

• Adjuvant breast cancer.

NEMLC RECOMMENDATION

• Approved
  (Fluoro-uracil plus Doxorubicin plus cyclophosphamide (FAC) ).

REVIEW INDICATORS

• None

DATE RATIFIED

• 27 November 2008